AI Article Synopsis
- Cholestatic patients face a higher risk of complications during surgery, and the exact reasons for this are still unclear.
- A study conducted on mice showed that those with the IFN-gamma receptor experienced less liver damage and jaundice after bile duct ligation than those without the receptor.
- The findings suggest that IFN-gamma may help protect the liver during cholestasis by promoting the removal of damaged cells, which in turn helps prevent further injury and inflammation.
Article Abstract
Cholestatic patients suffer from high perioperative morbidity and mortality, but the pathophysiology is still unknown. Interferon gamma (IFN-gamma) may play a role during cholestasis. Therefore, bile duct ligation (BDL) was induced in IFN-gamma alpha-chain receptor-deficient (IFN-gammaR(1)-/-) and wild-type (IFN-gammaR(1)+/+) mice. BDL elicited increased IFN-gamma messenger RNA and protein levels in the liver. One week after BDL, IFN-gammaR(1)+/+ mice showed less severe jaundice and liver injury than IFN-gammaR(1)-/- mice, as reflected by lower bilirubin and liver enzyme levels. In accordance, livers of IFN-gammaR(1)+/+ mice displayed smaller areas of necrosis by two-thirds than IFN-gammaR(1)-/- mice on histopathologic examination (P <.05), whereas mitotic activity and proliferating cell nuclear antigen (PCNA) labeling index was more than twice as high in IFN-gammaR(1)+/+ mice (P <.05). Livers of IFN-gammaR(1)+/+ mice displayed higher rates of apoptosis as indicated by DNA fragmentation rate, the number of apoptotic bodies, and poly ADP-ribose polymerase (PARP) immunostaining. BDL was not associated with lethality in IFN-gammaR(1)+/+ mice; IFN-gammaR(1)-/- mice, however, died from 10 days onward and survival after 2 weeks was 62% (10 of 16). In conclusion, these data suggest that IFN-gamma protects against liver injury during extrahepatic cholestasis by stimulation of apoptosis and subsequent proliferation of hepatocytes, leading to elegant removal of damaged hepatocytes, thus preventing necrosis and concomitant inflammatory responses.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1053/jhep.2002.37196 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Tumor growth suppression in adoptive T cell therapy via IFN-γ targeting of tumor vascular endothelial cells.
Theranostics
December 2024
Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
In adoptive T cell therapy (ACT), the direct cytotoxic effects of CD8 T cells on tumor cells, including the release of interferon-gamma (IFN-γ), are considered the primary mechanism for tumor eradication. Cancer antigen escape diminishes the T cell responses, thereby limiting the therapeutic success. The impacts of IFN-γ targeting non-tumor cells in ACT, on the other hand, remains under-investigated.
View Article and Find Full Text PDFTh1 cells reduce the osteoblast-like phenotype in valvular interstitial cells by inhibiting NLRP3 inflammasome activation in macrophages.
Mol Med
July 2024
Department of Cardiology, Liuzhou People's Hospital, Guangxi, Zhuang Autonomous Region, Wenchang Road 8, Liuzhou, 545000, P.R. China.
Background And Aims: Inflammation is initiates the propagation phase of aortic valve calcification. The activation of NLRP3 signaling in macrophages plays a crucial role in the progression of calcific aortic valve stenosis (CAVS). IFN-γ regulates NLRP3 activity in macrophages.
View Article and Find Full Text PDFInterferon-gamma signaling promotes cartilage regeneration after injury.
Sci Rep
April 2024
Division of Rheumatology, Department of Internal Medicine, Hallym University Sacred Heart Hospital, 896, Pyungchon, Anyang, Kyunggi, 14068, Korea.
Osteoarthritis is a common chronic disease and major cause of disability and chronic pain in ageing populations. In this pathology, the entire joint is involved, and the regeneration of articular cartilage still remains one of the main challenges. Here, we investigated the molecular mechanisms underlying cartilage regeneration in young mice using a full-thickness cartilage injury (FTCI) model.
View Article and Find Full Text PDFLack of IFN-γ Receptor Signaling Inhibits Graft-versus-Host Disease by Potentiating Regulatory T Cell Expansion and Conversion.
J Immunol
September 2023
Key Laboratory of Organ Regeneration and Transplantation of the Ministry of Education, National-Local Joint Engineering Laboratory of Animal Models for Human Diseases, The First Hospital of Jilin University, Changchun, China.
Article Synopsis
- IFN-γ is a cytokine that has a debated effect on regulatory T cell (Treg) activity, particularly in the context of allogeneic hematopoietic cell transplant (allo-HCT) for leukemia treatment.
- The study shows that signaling through the IFN-γ receptor (IFN-γR) inhibits Treg expansion and the conversion of regular T cells to Tregs, leading to worse outcomes like graft-versus-host disease (GVHD) and reduced graft-versus-leukemia (GVL) effects.
- Results from mouse models and human studies suggest that impairing IFN-γR signaling may enhance Treg function and help achieve GVL effects while minimizing GVHD, indicating a potential
Article Synopsis
- * Tspan8 is downregulated in ulcerative colitis in mice, which disrupts cell junctions and increases epithelial permeability, thereby upregulating Stat1 signaling.
- * Tspan8 is linked to lipid rafts and influences the endocytosis route of the IFN-γ receptor, which helps maintain intestinal epithelial integrity and minimizes inflammation.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!